Your browser doesn't support javascript.
loading
Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer.
Ryan, Stephen T; Zhang, Jing; Burner, Danielle N; Liss, Michael; Pittman, Emily; Muldong, Michelle; Shabaik, Ahmed; Woo, Jason; Basler, Nicole; Cunha, Jonathan; Shalapour, Shabnam; Estrada, Monica V; Karin, Michael; Messer, Karen; Howell, Stephen; Kane, Christopher J; Jamieson, Christina A M.
Afiliação
  • Ryan ST; Department of Urology, UCSD Moores Cancer Center, University of California San Diego School of Medicine, 3855 Health Sciences Drive, Mail Code: 0987, La Jolla, CA, 92093-0987, USA.
  • Zhang J; Department of Pharmacology, University of California San Diego School of Medicine, La Jolla, CA, USA.
  • Burner DN; Department of Urology, UCSD Moores Cancer Center, University of California San Diego School of Medicine, 3855 Health Sciences Drive, Mail Code: 0987, La Jolla, CA, 92093-0987, USA.
  • Liss M; Department of Urology, University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
  • Pittman E; Department of Pharmacology, University of California San Diego School of Medicine, La Jolla, CA, USA.
  • Muldong M; Department of Urology, UCSD Moores Cancer Center, University of California San Diego School of Medicine, 3855 Health Sciences Drive, Mail Code: 0987, La Jolla, CA, 92093-0987, USA.
  • Shabaik A; Department of Pathology, University of California San Diego School of Medicine, La Jolla, CA, USA.
  • Woo J; Department of Urology, UCSD Moores Cancer Center, University of California San Diego School of Medicine, 3855 Health Sciences Drive, Mail Code: 0987, La Jolla, CA, 92093-0987, USA.
  • Basler N; Department of Urology, UCSD Moores Cancer Center, University of California San Diego School of Medicine, 3855 Health Sciences Drive, Mail Code: 0987, La Jolla, CA, 92093-0987, USA.
  • Cunha J; Department of Urology, UCSD Moores Cancer Center, University of California San Diego School of Medicine, 3855 Health Sciences Drive, Mail Code: 0987, La Jolla, CA, 92093-0987, USA.
  • Shalapour S; Department of Pharmacology, University of California San Diego School of Medicine, La Jolla, CA, USA.
  • Estrada MV; Biorepository and Tissue Technology Shared Resource at the University of California San Diego School of Medicine, La Jolla, CA, USA.
  • Karin M; Department of Pharmacology, University of California San Diego School of Medicine, La Jolla, CA, USA.
  • Messer K; Department of Pharmacology, University of California San Diego School of Medicine, La Jolla, CA, USA.
  • Howell S; Department of Pharmacology, University of California San Diego School of Medicine, La Jolla, CA, USA.
  • Kane CJ; Division of Biostatistics, Department of Family and Preventive Medicine, University of California San Diego School of Medicine, La Jolla, CA, USA.
  • Jamieson CAM; Department of Pharmacology, University of California San Diego School of Medicine, La Jolla, CA, USA.
J Transl Med ; 18(1): 214, 2020 05 28.
Article em En | MEDLINE | ID: mdl-32466781
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male Idioma: En Revista: J Transl Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male Idioma: En Revista: J Transl Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos